COVID-19 Test Kit Rapid Test

PRODUCT FEATURES

1. Test samples: serum, plasma, venous whole blood specimen
2. Total antibody detection using the double antigen sandwich method, which
greatly improves sensitivity and specificity;
3. Total antibody detection shortens the detection window period
4. Rapidly screen for novel coronavirus within 15 minutes
5. No need instrument, suitable for on-site screening
6. Reduce the risk of individual infection in the hospital
7. Early diagnosis, early treatment, shorten the course of the disease
8. Reduce the workload of the designated hospital

SPECIFICATIONS

20T/Kit

STORAGE CONDITIONS

4-30°C

2019-nCov Ab Test (colloidal Gold)
*NMPA approved product under National Emergency Assesssment

igM and igG Combined Detection

The clinical auxiliary diagnosis of 2019-nCoV requires simple, economical and feasible methods. The human immune system can produce specific IgM and IgG antibodies after virus infection. IgM is the earliest antibody that appears upon the first immune response. The detection of IgM antibody indicates a recent infection and can be used as auxiliary diagnosis of early infection. IgG is produced later and lasts long, which can be used as an indicator of previous or secondary infection. The kit is intended for the qualitative detection of IgM and IgG antibodies against 2019 Novel Coronavirus (2019-nCoV) in human serum/plasma/venous whole blood specimen and for the auxiliary diagnosis of 2019-nCoV infection. The confirmation or exclusion of infection will be combined with the patient’s clinical manifestations or further other methods.

CE & EN ISO13458